Author

A. B. Dogan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:drug response / drug discovery· 3 Organism:mouse· 1 Assay:protein structure· 1 Organism:rat· 1

Frequent Co-Authors

H. A. von Recum· 4 shared A. A. Exner· 1 shared A. B. Desai· 1 shared C. Hernandez· 1 shared H. von Recum· 1 shared J. A. Kilgore· 1 shared J. N. P. Smith· 1 shared K. Dabkowski· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersBioengineering

H. A. von Recum

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Conventional polymers may unintentionally refill in vivo with unassociated drugs

K. Young, A. B. Dogan, C. Hernandez, A. A. Exner, H. A. von Recum

This paper investigates the refilling capacity of PLGA implants, finding that even unmodified PLGA can refill with unassociated drugs, contrary to expectations.

bioRxiv · Mar 21, 2022 · PreprintBioengineering

Polymer microparticles prolong delivery of the 15-PGDH inhibitor SW033291

A. B. Dogan, N. A. Rohner, J. N. P. Smith, J. A. Kilgore, N. S. Williams, S. D. Markowitz, H. A. von Recum, A. B. Desai

This paper develops a sustained release platform using β-CD microparticles to extend the delivery of the 15-PGDH inhibitor SW033291 beyond one week.

bioRxiv · Aug 15, 2021Bioengineering

Polymer additives to personal protective equipment can inactivate pathogens

A. B. Dogan, K. E. Dabkowski, H. A. von Recum

This paper introduces a method to inactivate pathogens using polymer additives in face masks, demonstrating effectiveness against both Gram-positive and Gram-negative bacteria.

bioRxiv · Apr 1, 2021Bioengineering

Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics

A. B. Dogan, K. Dabkowski, H. von Recum

This paper develops protein-polymer conjugates with high-affinity adamantane caps to enable sustained drug delivery of proteins, achieving up to 65 days of release without compromising structure/function.

bioRxiv · Dec 3, 2020Bioengineering

Engineering Selective Molecular Tethers to Enhance Suboptimal Drug Properties

A. B. Dogan, H. A. von Recum

This paper demonstrates that tethering small-molecule drugs to high-affinity groups improves their affinity for cyclodextrin polymers, enhancing drug delivery without compromising cellular activity.

bioRxiv · Feb 1, 2020Bioengineering